BACKGROUND: Coronary angioplasty is being increasingly performed in complex lesions of the unprotected and protected left main (LM) coronary artery. OBJECTIVES: To assess the impact of patient and operator related clinical variables of success and to evaluate the subsequent mid-term effects of percutaneous treatment of LM coronary stenosis. METHODS: In a tertiary referral, high-volume angioplasty centre a total of 118 consecutive surgical and nonsurgical patients with protected and unprotected LM lesions were treated and evaluated in a retrospective observational study. RESULTS: There were 57 protected and 61 unprotected patients, including 13 patients with an acute myocardial infarction (AMI). Mean age was 67 years (range 33-90). The length of the stenotic segment was 4.8±2.3 mm, mean lumen diameter 1.1±0.6 mm and percentage diameter stenosis 63.6±14.6%. There were seven (5.9%) in-hospital cardiac deaths which presented with AMI and cardiogenic shock. All seven patients had unprotected LM lesions. Average follow-up was eight months (range 1 to 36 months). Major adverse cardiac events (MACE) during follow-up comprised eight (6.8%) cardiac deaths, three (2.5%) myocardial infarctions, eight (6.8%) subjects with coronary bypass surgery and 16 (13.6%) repeated angioplasties. The total event rate (MACE, n=43) at the end of the follow-up period was 36.4%. There were more MACE in the unprotected group than in the protected group (41 vs. 31.6%, p<0.05). CONCLUSION: This study supports prior data on LM angioplasty. LM stenting in AMI, however, showed less favourable in-hospital and late outcome.
BACKGROUND: Coronary angioplasty is being increasingly performed in complex lesions of the unprotected and protected left main (LM) coronary artery. OBJECTIVES: To assess the impact of patient and operator related clinical variables of success and to evaluate the subsequent mid-term effects of percutaneous treatment of LM coronary stenosis. METHODS: In a tertiary referral, high-volume angioplasty centre a total of 118 consecutive surgical and nonsurgical patients with protected and unprotected LM lesions were treated and evaluated in a retrospective observational study. RESULTS: There were 57 protected and 61 unprotected patients, including 13 patients with an acute myocardial infarction (AMI). Mean age was 67 years (range 33-90). The length of the stenotic segment was 4.8±2.3 mm, mean lumen diameter 1.1±0.6 mm and percentage diameter stenosis 63.6±14.6%. There were seven (5.9%) in-hospital cardiac deaths which presented with AMI and cardiogenic shock. All seven patients had unprotected LM lesions. Average follow-up was eight months (range 1 to 36 months). Major adverse cardiac events (MACE) during follow-up comprised eight (6.8%) cardiac deaths, three (2.5%) myocardial infarctions, eight (6.8%) subjects with coronary bypass surgery and 16 (13.6%) repeated angioplasties. The total event rate (MACE, n=43) at the end of the follow-up period was 36.4%. There were more MACE in the unprotected group than in the protected group (41 vs. 31.6%, p<0.05). CONCLUSION: This study supports prior data on LM angioplasty. LM stenting in AMI, however, showed less favourable in-hospital and late outcome.
Entities:
Keywords:
acute myocardial infarction; clinical outcome; left main angioplasty
Authors: S C Smith; J T Dove; A K Jacobs; J W Kennedy; D Kereiakes; M J Kern; R E Kuntz; J J Popma; H V Schaff; D O Williams; R J Gibbons; J P Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith Journal: Circulation Date: 2001-06-19 Impact factor: 29.690
Authors: Seung-Jung Park; Won Heum Shim; David S Ho; Albert E Raizner; Seong-Wook Park; Myeong-Ki Hong; Cheol Whan Lee; Donghoon Choi; Yangsoo Jang; Ricky Lam; Neil J Weissman; Gary S Mintz Journal: N Engl J Med Date: 2003-04-17 Impact factor: 91.245
Authors: E Regar; P W Serruys; C Bode; C Holubarsch; J L Guermonprez; W Wijns; A Bartorelli; C Constantini; M Degertekin; K Tanabe; C Disco; E Wuelfert; M C Morice Journal: Circulation Date: 2002-10-08 Impact factor: 29.690
Authors: John G Webb; April M Lowe; Timothy A Sanborn; Harvey D White; Lynn A Sleeper; Ronald G Carere; Christopher E Buller; S Chiu Wong; Jean Boland; Vlad Dzavik; Mark Porway; Gordon Pate; Geoffrey Bergman; Judith S Hochman Journal: J Am Coll Cardiol Date: 2003-10-15 Impact factor: 24.094
Authors: Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico Journal: N Engl J Med Date: 2002-06-06 Impact factor: 91.245